Market Place
Sourcing Support
All News #Library
Rare Diseases
FDA Reversals Highlight Confusion Over External Controls
06 Apr 2026 //
BIOSPACE
FDA official calls UniQure`s Huntington`s disease treatment a fai
06 Mar 2026 //
REUTERS
Uniqure Faces Ethical Hurdles Ahead Of Huntington`s Gene Therapy
05 Mar 2026 //
BIOSPACE
Uniqure Halts Mid- To High-Dosing For AAV Gene Therapy
06 Feb 2026 //
FIERCE BIOTECH
uniQure Updates on AMT-130 for Huntington`s Disease
02 Jun 2025 //
GLOBENEWSWIRE
uniQure`s AMT-130 Granted FDA Breakthrough Therapy for Huntington
17 Apr 2025 //
GLOBENEWSWIRE
UniQure Gets Orphan Drug Designation For AMT-191 In Fabry
23 Sep 2024 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.